Browsing Tag
HER2-positive cancer
2 posts
Abpro and Celltrion reveal promising preclinical results for ABP-102/CT-P72 at AACR 2025
Discover how Abpro and Celltrion’s ABP-102/CT-P72 could reshape HER2 cancer treatment with promising preclinical results. Read the full details now!
Seattle Genetics to acquire Cascadian Therapeutics for $614m to bolster oncology portfolio
Seattle Genetics, a leader in oncology biotechnology, has announced the acquisition of Cascadian Therapeutics for approximately $614 million,…